DDW has added Fatah Kashanchi, PhD, Professor, George Mason University and Heather Branscome, MS, PhD, Senior Scientist, ATCC to its track, Concept to Cure: Curiosity and Lab Automation in Drug Discovery at SLAS2025 (25-29 January 2025, San Diego, USA).

Heather Branscome
Fatah Kashanchi

This free programme, which will run on 27, 28 and 29 January, will present examples of research and drug development from industry experts using lab automation and technology.

Kashanchi and Branscome’s talk will be: From curiosity to breakthroughs: Accelerate your drug development with assay ready cells. It will take place in the Ignite Theater on 28 January.

Dr Kashanchi, a tenured faculty at George Mason University, specialises in RNA viral infections. He has secured over $28.9M in funding and published 270-plus peer-reviewed manuscripts. With an h-index of 76, he serves on editorial boards of top journals and has been a regular NIH study section member, serving on 163 panels and chairing 21 since 2000.

Dr Heather Branscome, Senior Scientist at ATCC, has over 17 years of experience in both academia and industry. Specialising in cell and mol

ecular biology, she leads a team supporting the CDC’s IRR program and manages ATCC’s extracellular vesicle portfolio, focusing on EV purification, characterisation, and stem cell-derived EV research.

Speaker line-up:

The track is sponsored by ATCC, Integra Biosciences, Collaborative Drug Discovery (CDD) and Tecan.

Register your interest here.